Sundaram Senthil Vel has filed 3 insider transactions across 1 company since November 2022.
Most recent transaction: a purchase of 2111 shares of Terns Pharmaceuticals, Inc. ($TERN) on May 31, 2023.
Activity breakdown: 2 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 31, 2023 | Terns Pharmaceuticals, Inc. | $TERN | Sundaram Senthil Vel | Chief Executive Officer | P | Common Stock | 2111 | $1.41 | 9,770.0000 | 0 | 27.56% | 0.00% |
| Nov. 30, 2022 | Terns Pharmaceuticals, Inc. | $TERN | Sundaram Senthil Vel | Chief Executive Officer | P | Common Stock | 3 | $1.41 | 7,659.0000 | 0 | 0.04% | 0.00% |
| Feb. 1, 2023 | Terns Pharmaceuticals, Inc. | $TERN | Sundaram Senthil Vel | Chief Executive Officer | A | Stock Option (Right to Buy) | 900000 | $0.00 | 900,000.0000 | 0 | 9999.99% | 0.00% |